The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor

Anti-Cancer Drugs

Volumn 7, Issue 7, 1996, Pages 745-751

  Didier, Agnes ^a   Loor, Francis ^a,b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b Sandoz Pharma Ltd   (Switzerland)

Author keywords

Ivermectin; Multidrug resistance; P glycoprotein; SDZ PSC 833

Indexed keywords

CYCLOSPORIN A; DAUNORUBICIN; DOXORUBICIN; GLYCOPROTEIN P; IVERMECTIN; SDZ 280446; VALSPODAR; VINBLASTINE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG RETENTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHATIC LEUKEMIA; MONOCYTIC LEUKEMIA; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029966747     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199609000-00005     Document Type: Article

References (9)

1. Loor F. Cyclosporins and related fungal products in the reversal of P-glycoprotein-mediated multidrug resistance. In: Gupta S, Tsuruo T, eds. Multidrug resistance in cancer cells: cellular, biochemical, molecular and biological aspects. Chichester: John Wiley 1996: 385-412.
2. Didier A, Loor F. Decreased biotolerability for ivermectin and cyclosporin A in mice exposed to potent P-glycoprotein inhibitors. Int J Cancer 1995; 63: 263-7.
3. Cefalu WT, Pardridge WM. Restrictive transport of a lipid-soluble peptide (cyclosporin) through the blood-brain barrier. J Neurochem 1985; 45: 1954-6.
4. Shirai A, Naito M, Tatsuta T, et al. Transport of cyclosporin A across the brain capillary endothelial cell monolayer by P-glycoprotein. Biochim Biophys Acta 1994; 1222: 400-4.
5. Tatsuta T, Naito M, Oh-Hara T, et al. Functional involvement of P-glycoprotein in blood-brain barrier. J Biol Chem 1992; 267: 20383-91.
6. Schinkel AH, Smit JJM, Van Tellingen O, et al. Disruption of the mouse mdr 1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994; 77: 491-502.
7. Fisher M, Mrozik H. The chemistry and pharmacology of avermectins. Annu. Rev. Pharmacol Toxicol 1992; 32: 537-53.
8. Didier A, Wenger J, Loor F. Decreased uptake of cyclosporin A by P-glycoprotein (Pgp) expressing CEM leukemic cells and restoration of normal retention by Pgp blockers. Anti-Cancer Drugs 1995; 6: 669-80.
9. Schmutterer H. Properties and potential of natural pesticides from the neem tree, Azadirachta indica. Annu Rev Entomol 1990; 35: 271-97.